drugset / Trial / NCT01285713
IV Glucose for Dehydration Treatment
Phase 2
Completed
83 enrolled
Children's Hospital of Philadelphia
Academic Pediatric Association · collabAmerican Academy of Pediatrics · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
To determine whether the addition of dextrose to IV fluids in the treatment of gastroenteritis leads to a decrease in serum ketones. Secondarily, the clinical benefits of dextrose containing fluids in the treatment of gastroenteritis will be assessed.
Timeline
- Start
- 2010-09
- Primary completion
- 2011-08
- Completion
- 2012-03
Outcome
Met primary endpoint
registry analysis (superiority or other test); D5Normal Saline vs Normal Saline; p = 0.0003; Paired t-test NCT01285713 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextrose | Unknown | 5 % | Intravenous |
| Comparator | sodium chloride | Unknown | 30 ml | Intravenous |
Indications
No indication recorded.